XML 37 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings (Loss) Per Share (Tables)
 9 Months Ended
Sep. 30, 2017
Earnings Per Share [Abstract]  
Calculations of Earnings (Loss) Per Share

The calculations of earnings (loss) per share are as follows:

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(In thousands, except per share amounts)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Basic Loss per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(17,462

)

 

$

157

 

 

$

(169,038

)

 

$

148

 

Less: Net income attributable to non-controlling interests

 

 

(163

)

 

 

(151

)

 

 

(352

)

 

 

(142

)

Less: Accretion of redemption preference on redeemable

   convertible non-controlling interest - Netsmart

 

 

(10,962

)

 

 

(10,191

)

 

 

(32,887

)

 

 

(18,344

)

Net loss attributable to Allscripts Healthcare Solutions, Inc.

   stockholders

 

$

(28,587

)

 

$

(10,185

)

 

$

(202,277

)

 

$

(18,338

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

180,634

 

 

 

186,226

 

 

 

180,864

 

 

 

187,190

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic Loss per Common Share

 

$

(0.16

)

 

$

(0.06

)

 

$

(1.12

)

 

$

(0.10

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Loss per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(17,462

)

 

$

157

 

 

$

(169,038

)

 

$

148

 

Less: Net income attributable to non-controlling interests

 

 

(163

)

 

 

(151

)

 

 

(352

)

 

 

(142

)

Less: Accretion of redemption preference on redeemable

   convertible non-controlling interest - Netsmart

 

 

(10,962

)

 

 

(10,191

)

 

 

(32,887

)

 

 

(18,344

)

Net loss attributable to Allscripts Healthcare Solutions, Inc.

   stockholders

 

$

(28,587

)

 

$

(10,185

)

 

$

(202,277

)

 

$

(18,338

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

180,634

 

 

 

186,226

 

 

 

180,864

 

 

 

187,190

 

Plus: Dilutive effect of stock options, restricted stock unit

   awards and warrants

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Weighted-average common shares outstanding assuming

   dilution

 

 

180,634

 

 

 

186,226

 

 

 

180,864

 

 

 

187,190

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Loss per Common Share

 

$

(0.16

)

 

$

(0.06

)

 

$

(1.12

)

 

$

(0.10

)

 
Anti-Dilutive Stock Options, Restricted Stock Unit Awards and Warrants Excluded from Computation of Diluted Earnings (Loss) Per Share

The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(In thousands)

 

2017

 

 

2016

 

 

2017

 

 

2016

 

Shares subject to anti-dilutive stock options, restricted stock

   unit awards and warrants excluded from calculation

 

 

26,085

 

 

 

27,580

 

 

 

26,636

 

 

 

26,219